Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CooperVision Surgical

This article was originally published in The Gray Sheet

Executive Summary

Argus Biomedical's AlphaCor artificial cornea will be the premier offering of Cooper's new ophthalmic surgical division. Cleared via 510(k) in 2002, AlphaCor is suitable for approximately 20,000 corneal implant patients each year, Cooper estimates. Through the purchase of Argus assets, announced Feb. 24, Cooper also acquired AlphaSphere soft orbital implants, still under development. Meanwhile, Ciba Vision divested most of its surgical business in early February, with French firm Ioltech, SA picking up the Vivarte refractive lens family along with several other lenses and surgical product lines...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts